Global pharmaceutical company Merck Sharp & Dohme (MSD) has established a data management center in Costa Rica, adding more jobs to the Central American country’s burgeoning services sector.
The center will process information on clinical studies in addition to keeping an account of cases of adverse effects caused by drugs sold globally. This is the company’s forth such facility, according to Costa Rica’s investment promotion agency, CINDE.
Employees at the center will develop reports on the drugs under clinical trial before they are released to the market.
“Proficiency in English is necessary to generate the reports” stated Claudia Molina, Director of the Center, explaining why the company chose to establish the center in Costa Rica.
“We are proud to know that it has found the conditions and highly specialized human talent required for a research center of this kind. This is the type of investments that we expect to continue…,” said Carlos Alvarado, President of Costa Rica, who was present at the time of inauguration.
MSD is not new to Costa Rica, where it has been present for more than 45 years. Last year, it launched financial services center in the Central American country to provide back-office services to its finance and accounting unit. Reports say more than 300 Costa Ricans are working for the center.
“During 2017, the high-added value exports represented 48% of the country’s services exports, this gives us a view of the country’s potential to work with operations that require a high-level knowledge,” said Luis Gamboa, Chairman of CINDE.